
Background: Sepsis is a life-threatening condition and a major cause of morbidity and mortality. There is increasing global emphasis on reducing hospital-acquired sepsis (HAS). However, hospital infection prevention and control (IPAC) programs have not traditionally participated in sepsis surveillance. This study describes the integration of sepsis surveillance into an IPAC program to support the early identification of sepsis events. Methods: A quality improvement initiative using the Plan-Do-Study-Act model was conducted across several Canadian hospitals between April 2023 and January 2025. Multimodal interventions included education and sepsis surveillance to classify sepsis as either community-acquired or hospital-acquired. A retrospective cohort pilot study was conducted between November 9, 2024, and January 31, 2025, through the review of electronic health records to identify the origin of sepsis, characterize infection sources associated with mortality risk, and validate data reporting for future prevention strategies. Results: During the study period, 248 real-time sepsis diagnosis alerts were reviewed, of which 232 (93.5%) were community-acquired and 16 (6.5%) were hospital-acquired. Mortality was significantly higher among patients with HAS (37.5%) than among those with community-acquired sepsis (12.5%) (RR = 3.0, 95% CI [1.46, 6.15], p = 0.014). Among 290 infection sources, 22 (7.6%) were hospital-acquired, with urinary tract infection (UTI) being the most common (31.8%). Mortality was significantly lower among patients with UTI sources (8.8%) than among those with non-UTI sources (18.7%) (RR = 0.47, 95% CI [0.28, 0.80], p = 0.040). From November to January, HAS rates increased from 3.80 to 5.71 per 1,000 discharges, with 16 of 25 cases validated by IPAC surveillance. Conclusions: The findings of the current study demonstrate higher mortality among patients with hospital-acquired sepsis than among those with community-acquired sepsis. This sepsis surveillance system may serve as a valuable addition to hospital surveillance and quality improvement programs by providing insights into sepsis classification and infection sources.
Background: Device-associated infections remain a major patient safety concern in intensive care units (ICUs), particularly in cardiovascular surgery settings where invasive device utilization is high. Methods: This retrospective surveillance study analyzed routinely collected infection prevention data from January 2023 to December 2025 in a cardiovascular surgery ICU. Infection rates were calculated per 1,000 device-days, and device utilization ratios were determined. Results: During the three-year study period, 3,387 patient-days were recorded, including 1,167 ventilator-days, 3,251 urinary catheter-days, and 2,664 central line-days. Device utilization ratios were 0.34 for ventilators, 0.96 for urinary catheters, and 0.79 for central lines. One ventilator-associated pneumonia (0.86 per 1,000 ventilator-days) and one central line-associated bloodstream infection (0.38 per 1,000 central line-days) were identified. No catheter-associated urinary tract infections were observed. Conclusions: Long-term surveillance data provide important context for device utilization and device-associated infection trends in specialized surgical ICUs. Sustained infection prevention and control measures may improve outcomes despite increased device utilization.
Background: Tetracyclines are widely used antibiotics and are receiving increasing attention for the post-exposure prophylaxis of sexually transmitted infections (STIs). Surveillance is needed to monitor community resistance to these agents. Methods: This surveillance study analyzed resistance data for the 15 most common bacterial isolates from all clinical specimens that underwent tetracycline, doxycycline, or minocycline susceptibility testing at LifeLabs British Columbia between 2020 and 2024. Antimicrobial susceptibility testing followed Clinical and Laboratory Standards Institute guidance. The study analyzed 563 doxycycline, 791 minocycline, and 266,721 tetracycline susceptibility test results. Results: A significant increase (p < 0.05) in tetracycline resistance was observed in Streptococcus pneumoniae [15.4% (n = 136) to 56.3% (n = 446)], Klebsiella pneumoniae [7.3% (n = 4,614) to 10.5% (n = 5,123)], and Enterococcus faecalis [73.7% (n = 5,404) to 75.7% (n = 6,010)]. No significant changes were observed in doxycycline resistance among methicillin-susceptible Staphylococcus aureus [0% (n = 39) to 3.0% (n = 67)], doxycycline resistance among methicillin-resistant Staphylococcus aureus [4.8% (n = 21) to 10.3% (n = 39)], or minocycline resistance in Stenotrophomonas maltophilia [0.9% (n = 106) to 0.8% (n = 125)]. Conclusion: The observed increase in resistance highlights the need for ongoing surveillance and judicious prescribing of tetracyclines, particularly as their use expands to indications such as post-exposure prophylaxis for STIs.
Background: Hand hygiene is a critical infection prevention measure, yet most initiatives in healthcare focus on healthcare workers rather than patients. Patients’ hands can become contaminated – particularly before meals – and contribute to the transmission of pathogens such as vancomycin-resistant Enterococcus (VRE). This study evaluated whether a simple, low-burden intervention could increase patient hand hygiene compliance and reduce VRE acquisition. Methods: Two sites within our hospital network implemented a quality improvement intervention in which patients received a single-use ethanol wipe on every meal tray, accompanied by various forms of instruction for use. Importantly, no staff involvement or workflow changes were required beyond awareness of the intervention. Patient hand hygiene adherence was self-reported through structured interviews conducted after meals, during which patients were asked to recall whether they had cleaned their hands before eating. One site used a concurrent control group for comparison, while the other used a pre/post study design. VRE incidence was measured using existing surveillance programs. Results: At the first site, self-reported hand hygiene before meals was significantly higher among patients receiving the intervention than among controls (91% vs. 70%), with 38% of those who cleaned their hands reporting use of the provided product. At the second site, a similar improvement was observed in the post-intervention group compared with the pre-intervention group (79% vs. 57%), with 34% of those who cleaned their hands reporting use of the provided product. Notably, VRE incidence in the intervention units at the first site decreased from 5.35 to 2.00 cases per 1,000 patient-days, while no hospital-wide change occurred. The intervention was inexpensive, costing approximately $0.40 CAD per patient per day, and was not associated with any reported harms. Conclusion: This study demonstrates that a simple, low-resource, patient-centred intervention can meaningfully increase patient hand hygiene and may reduce VRE transmission. These findings support further evaluation in other settings and populations.
In the Fall 2025 issue of the Canadian Journal of Infection Control, Candon et al. (2025) published a letter to the editor in which they proposed self-regulation of Infection Prevention and Control (IPAC) professionals in Ontario, Canada. In their submission, they suggested that the lack of regulation of the profession represents a critical gap in Ontario’s healthcare system. This letter contributes to the conversation by providing a nuanced perspective on the regulation of IPAC practice.